Abstract
Cellular adhesion molecules have been implicated in tumour progression and metastasis. This study examines for the first time the serum concentrations of circulating VCAM-1 and E-selectin in a consecutive series of 110 cancer patients seen in a general medical oncology clinic, and confirms and extends previous studies reporting measurement of circulating ICAM-1. Soluble ICAM-1 and VCAM-1 levels were significantly higher in all the patient groups compared with the controls whereas soluble E-selectin was significantly higher in the ovarian, breast and GI cancer groups and lower in the myeloma group. The significance of these results together with the possible sources and stimuli for release of these adhesion molecules are discussed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Banks, R., Gearing, A., Hemingway, I. et al. Circulating intercellular adhesion molecule-1 (ICAM-1), E-selectin and vascular cell adhesion molecule-1 (VCAM-1) in human malignancies. Br J Cancer 68, 122–124 (1993). https://doi.org/10.1038/bjc.1993.298
Issue Date:
DOI: https://doi.org/10.1038/bjc.1993.298
- Springer Nature Limited
This article is cited by
-
VCAM-1 complements CA-125 in detecting recurrent ovarian cancer
Clinical Proteomics (2023)
-
Ablation of VLA4 in multiple myeloma cells redirects tumor spread and prolongs survival
Scientific Reports (2022)
-
Bisphenol A induces ovarian cancer cell proliferation and metastasis through estrogen receptor-α pathways
Environmental Science and Pollution Research (2021)
-
High preoperative serum sVCAM-1 concentration as a predictor of early ovarian cancer recurrence
Journal of Ovarian Research (2020)
-
Acute Coronary Syndrome in Cancer Patients
American Journal of Cardiovascular Drugs (2018)